Betulinic acid derivative F6 selectively blocked intestinal FXR yet activated hepatic FXR to reduce harmful ceramides and inflammation, which ameliorated hepatic steatosis, inflammation, and fibrosis (Zhang et al., 2022). This evidence concerns the gene NR1H4 and Hepatic steatosis.